Ticker Search:  Getting Started | Register | Videos | Newsletter | Partners | Login    

Basics
ABBVIE INC.
AbbVie Inc is a biopharmaceutical company that discovers, develops, manufactures and sells a range of pharmaceutical products for treating chronic autoimmune diseases, virology and neurological disorders.
IPO Date: December 14, 2012
Sector: Healthcare
Industry: Drug Manufacturers
Market Cap: $337.14B
Activated in VL: True
Average Daily Range
Avg Daily Range: $0.98 | 1.02%
Avg Daily Range (30 D): $1.80 | 0.98%
Avg Daily Range (90 D): $2.63 | 1.37%
Institutional Daily Volume
Avg Daily Volume: 6.32M
Avg Daily Volume (30 D): 4.68M
Avg Daily Volume (90 D): 5.4M
Trade Size
Avg Trade Size (Sh.): 108
Avg Trade Size (Sh.) (30 D): 55
Avg Trade Size (Sh.) (90 D): 57
Institutional Trades
Total Inst.Trades: 60,689
Avg Inst. Trade: $9.52M
Avg Inst. Trade (30 D): $23.47M
Avg Inst. Trade (90 D): $24.23M
Avg Inst. Trade Volume: .09M
Avg Inst. Trades (Per Day): 19
Market Closing Trades
Avg Closing Trade: $88.06M
Avg Closing Trade (30 D): $213.08M
Avg Closing Trade (90 D): $245.91M
Avg Closing Volume: 797.83K
   
News
Jun 20, 2025 @ 7:39 PM
Obesity Drugs Help With Weight Loss But Are Adding...
Source: Vandana Singh
Jun 19, 2025 @ 2:58 PM
Artificial Intelligence (AI) Collaboration, R&D, a...
Source: Researchandmarkets.Com
Jun 17, 2025 @ 2:43 PM
AbbVie's Cancer Drug Venetoclax Falls Short In Pha...
Source: Vandana Singh
Jun 12, 2025 @ 5:00 PM
Giant-Cell Arteritis Market Heats up with AbbVieâ...
Source: Delveinsight
Jun 11, 2025 @ 9:07 PM
FDA Expands AbbVie's Mavyret Label To Include Acut...
Source: Vandana Singh
Financials
  TTM Q1 2025 Q3 2024
Basic EPS $.72 $.88
Diluted EPS $.72 $.88
Revenue $ $ 13.34B $ 14.46B
Gross Profit $ $ 9.34B $ 10.25B
Net Income / Loss $ $ 1.29B $ 1.56B
Operating Income / Loss $ $ 3.73B $ 3.83B
Cost of Revenue $ $ 4B $ 4.21B
Net Cash Flow $ $ -349M $ -5873M
PE Ratio